Stem cells are often seen as potential agents in the field of regenerative medicine. What are the realities and what should doctors expect? Dr. Marc Hedrick, president of San Diego-based Cytori Therapeutics, tells the Chicago Tribune's Bruce Japsen about commercialized treatments already being used, and even more on the horizon.
Real Uses for Stem Cells On the Horizon
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Stem cells are often seen as potential agents in the field of regenerative medicine. What are the realities and what should doctors expect? Dr. Marc Hedrick, president of San Diego-based Cytori Therapeutics, tells the Chicago Tribune's Bruce Japsen about commercialized treatments already being used, and even more on the horizon.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?